Digital RESI Pitch Session

Interested in Connecting? Please contact:
J. Kent Werner
CEO
kent@cogentistx.com

Message the company or request a 1:1 meeting here

Cogentis discovers and develops first-in-class therapeutics that prevent neurodegeneration and restore brain function to benefit the lives of those patients and their families.

We want to cure the most debilitating of neurodegenerative disorders – Alzheimer’s disease, fronto-temporal dementia (FTD), progressive supranuclear palsy (PSP), Parkinson’s disease and more. We imagine a world where our research leads to breakthrough treatments so that no one has to suffer from dementia again.

Pitch Video